Salts of N- [6-cis-2,6-dimethylmorpholin-4yl)pyridin e-3yl]-2-methyl-4'- (trifluoromethoxy)[1,1'-biphenyl]-3-carbo xamide

Details for Australian Patent Application No. 2009293444 (hide)

Owner Novartis AG

Inventors Bajwa, Joginder Singh; De La Cruz, Marilyn; Dodd, Stephanie Kay; Waykole, Liladhar Murlidhar; Wu, Raeann

Agent Davies Collison Cave

Pub. Number AU-B-2009293444

PCT Pub. Number WO2010/033481

Priority 61/097,580 17.09.08 US

Filing date 15 September 2009

Wipo publication date 25 March 2010

Acceptance publication date 15 March 2012

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/5377 (2006.01)

A61K 35/00 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

Event Publications

17 March 2011 PCT application entered the National Phase

  PCT publication WO2010/033481 Priority application(s): WO2010/033481

15 March 2012 Application Accepted

  Published as AU-B-2009293444

12 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009293445-Drug eluting superhydrophobic coatings

2009293439-Off-line activation/loading of preauthorized and cleared payment cards